← All stocks

Ovid Therapeutics Inc.

OVID Net buying
CIK 0001636651 #3040 in the set updated 21 Sep 2026
Bought (120 mo)
$5.63M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$197.92K
$0.00 on a plan · $126.20K straight out of an exercise
Sold at will
$71.72K
5 of 6 sales
Net
+$5.43M
+$5.56M against sales at will

By person

14 insiders · 17 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TAKEDA PHARMACEUTICAL CO LTD entity
10% owner
$5.00M (1)
+$5.00M
12,750,000
$18.49M
+34.2%
LEVIN JEREMY M
Executive Chairman
$509.57K (5)
+$509.57K
3,770,509
$5.47M
−9.9%
Rakhit Amit
President and CMO
$126.20K (1) scheduled
−$126.20K
726,823
$1.05M
0.0%
Bernstein Karen
Director
$82.51K (2)
+$82.51K
20,000
$29.00K
Tardio Jason
Chief Operating Officer
$37.29K (1)
−$37.29K
28,125
$40.78K
+62.2%
WILLIAMS DOUGLAS E
Director
$32.44K (1)
+$32.44K
5,000
$7.25K
ALEXANDER MARGARET A.
President and CEO
$4.97K (1)
$19.86K (2)
−$14.89K
61,750
$89.54K
+119.6%
Rona Jeffrey A
CBFO
$14.57K (2)
−$14.57K
156,313
$226.65K
+443.6%
During Matthew
Director
4,679,406
$6.79M
+0.6%
PAPADOPOULOS STELIOS
Director
217,578
$315.49K
+8.8%
Carter Charles Ross
Chief Financial Officer
94,375
$136.84K
+112.7%
Perone Thomas Michael
General Counsel, Secretary
28,125
$40.78K
Fitzgerald Kevin Joseph
Director
17,578
$25.49K
Friedman Bart
Director
8,789
$12.74K

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 71,009,866 to 195,297,857 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
LEVIN JEREMY M
23 Mar 2026
Executive Chairman
Exercised, kept
47,333
$1.40
$66.27K
Rona Jeffrey A
23 Feb 2026
CBFO
Sell
8,541
$1.45
$12.38K
ALEXANDER MARGARET A.
23 Feb 2026
President and CEO
Sell
11,656
$1.45
$16.90K
Rona Jeffrey A
26 Feb 2025
CBFO
Sell
3,902
$0.56
$2.19K
ALEXANDER MARGARET A.
26 Feb 2025
President and COO
Sell
5,279
$0.56
$2.96K
ALEXANDER MARGARET A.
27 Jan 2025
President and COO
Buy
6,810
$0.73
$4.97K
LEVIN JEREMY M
18 Mar 2024
CEO
Buy
18,248
$2.76
$50.36K
Tardio Jason
12 Sep 2022
Chief Operating Officer
Sell
17,344
$2.15
$37.29K
Rakhit Amit
14 Jul 2021
President and CMO
Sold after exercise
34,017
$3.71
$126.20K
LEVIN JEREMY M
28 Aug 2020
CEO
Buy
8,488
$5.84
$49.57K
LEVIN JEREMY M
8 Oct 2019
CEO
Buy
60,000
$2.50
$150.00K
TAKEDA PHARMACEUTICAL CO LTD
8 Oct 2019
10% owner
Buy indirect
2,000,000
$2.50
$5.00M
Bernstein Karen
26 Feb 2019
Director
Buy
10,000
$2.02
$20.21K
LEVIN JEREMY M
22 Feb 2019
CEO
Buy
75,000
$2.00
$150.00K
WILLIAMS DOUGLAS E
14 Aug 2018
Director
Buy
5,000
$6.49
$32.44K
Bernstein Karen
14 Aug 2018
Director
Buy
10,000
$6.23
$62.30K
LEVIN JEREMY M
25 Aug 2017
CEO
Buy
15,334
$7.15
$109.64K

What was left out

Form 4 filings counted 157
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 14,846,701
Sales filed before the plan box existed 1
History held since 10 May 2017